Holler A, Zech M, Ghorashian S, Pike R, Hotblack A, Veliça P, Xue S-A, Chakraverty R, Morris EC, Stauss HJ. Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy. Haematologica [Internet]. 2016Mar.31 [cited 2026Nov.1];101(4):482-90. Available from: https://haematologica.org/article/view/7684